|
An internal biomérieux investigation was completed.The customer no longer had the strain, so it could not be submitted for investigational testing.Submittal of the isolates is required in order to confirm a vitek® 2 discrepancy compared to the reference methods.Since the strains could not be submitted for investigational purposes, no additional investigation could be completed.Ast-gp67 lot 1321130103 met final qc release criteria.This lot passed qc performance testing.
|
|
A customer in the united states notified biomérieux of obtaining a false positive cefoxitin screen when testing a staphylococcus aureus patient isolate with the vitek® 2 ast-gp67 test kit (reference # 22226, lot # 1321130103).The customer was trying to validate the ast-gp75 card and received conflicting results.Ast-gp67 card: oxacillin mic = 2 susceptible, cefoxitin screen = positive, set up from original culture.Ast-gp75 card: oxacillin mic <= 0.25, cefoxitin screen = negative, set up from purity plate.Repeat testing of the ast-gp67 card: oxacillin mic = 2 susceptible, cefoxitin screen = negative.There is no indication or report from the hospital that the discrepant result led to any adverse event related to the patient's state of health.
|